Philip Kantoff: search on Z-Library

Fundraising September 15, 2024 – October 1, 2024 About fundraising

The world's largest scientific articles store. 70,000,000+ articles for free.

Fundraising September 15, 2024 – October 1, 2024

Z-Library is one of the largest online libraries in the world that contains over 17,000,000 books and 84,837,000 articles. We aim to make literature accessible to everyone. Today (September 15, 2024) we've started additional fundraising to project maintenance and development.

Also UNLIMITED downloads (for 31 days after the day of making donation) are available for ALL contributors who will donate during the fundraising period till October 1, 2024.

About fundraisingRead more

Make a donation

1

Cancer nanomedicine: progress, challenges and opportunities

Shi, Jinjun, Kantoff, Philip W., Wooster, Richard, Farokhzad, Omid C.

Journal:

Nature Reviews Cancer

Year:

2016

Language:

english

File:

PDF, 994 KB

english, 2016

2

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

Nuhn, Philipp, De Bono, Johann S., Fizazi, Karim, Freedland, Stephen J., Grilli, Maurizio, Kantoff, Philip W., Sonpavde, Guru, Sternberg, Cora N., Yegnasubramanian, Srinivasan, Antonarakis, Emmanuel S

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 650 KB

english, 2018

3

Effects of a gift certificate incentive and specialized delivery on prostate cancer survivors' response rate to a mailed survey: A randomized-controlled trial

Bakan, Jennifer, Chen, Bing, Medeiros-Nancarrow, Cheryl, Hu, Jim C., Kantoff, Philip W., Recklitis, Christopher J.

Journal:

Journal of Geriatric Oncology

Year:

2014

Language:

english

File:

PDF, 390 KB

english, 2014

4

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Sartor, Oliver, Armstrong, Andrew J., Ahaghotu, Chiledum, McLeod, David G., Cooperberg, Matthew R., Penson, David F., Kantoff, Philip W., Vogelzang, Nicholas J., Hussain, Arif, Pieczonka, Christopher

Journal:

Prostate Cancer and Prostatic Diseases

Year:

2020

File:

PDF, 628 KB

2020

5

Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time

Arlen, Philip M., Bianco, Fernando, Dahut, William L., D'Amico, Anthony, Figg, William D., Freedland, Stephen J., Gulley, James L., Kantoff, Philip W., Kattan, Michael W., Lee, Andrew, Regan, Meredith

Journal:

The Journal of Urology

Year:

2008

Language:

english

File:

PDF, 87 KB

english, 2008

6

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Kantoff, Philip W., Higano, Celestia S., Shore, Neal D., Berger, E. Roy, Small, Eric J., Penson, David F., Redfern, Charles H., Ferrari, Anna C., Dreicer, Robert, Sims, Robert B., Xu, Yi, Frohlich, Ma

Journal:

Boston Medical and Surgical Journal

Year:

2010

Language:

english

File:

PDF, 857 KB

english, 2010

7

Treatment of Advanced Prostate Cancer

Teo, Min Yuen, Rathkopf, Dana E., Kantoff, Philip

Journal:

Annual Review of Medicine

Year:

2019

File:

PDF, 383 KB

2019

8

Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial

Liou, Kevin T., Root, James C., Garland, Sheila N., Green, Jamie, Li, Yuelin, Li, Q. Susan, Kantoff, Philip W., Ahles, Tim A., Mao, Jun J.

Journal:

Year:

2020

File:

PDF, 219 KB

2020

9

Regulation of S100P expression by androgen

Averboukh, Lidia, Liang, Peng, Kantoff, Philip W., Pardee, Arthur B.

Journal:

Year:

1996

Language:

english

File:

PDF, 531 KB

english, 1996

10

CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians

Giovannucci, Edward, Stampfer, Meir J., Chan, Andrew, Krithivas, Krishna, Gann, Peter H., Hennekens, Charles H., Kantoff, Philip W.

Journal:

Year:

1999

Language:

english

File:

PDF, 118 KB

english, 1999

11

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

William K. Oh, Judith Manola, Jerome P. Richie, Kevin R. Loughlin, Philip W. Kantoff

Journal:

Year:

1999

Language:

english

File:

PDF, 78 KB

english, 1999

12

Hormonal perturbations in patients with testicular cancer treated with cisplatin

Gerald A. Leblanc, Philip W. Kantoff, Sze-Fong Ng, Emil Frei III, David J. Waxman

Journal:

Year:

1992

Language:

english

File:

PDF, 480 KB

english, 1992

13

Meningeal carcinomatosis from transitional cell carcinoma of the bladder

Charis Eng, David Cunningham, Bradley J. Quade, Lee Schwamm, Philip W. Kantoff, Arthur T. Skarin

Journal:

Year:

1993

Language:

english

File:

PDF, 528 KB

english, 1993

14

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer : A Phase II study

Matthew R. Smith, Donald Kaufman, William Oh, Kimberly Guerin, Michael Seiden, Thomas Makatsoris, Judith Manola, Philip W. Kantoff

Journal:

Year:

2000

Language:

english

File:

PDF, 67 KB

english, 2000

15

Low bone mineral density in hormone-naïve men with prostate carcinoma

Matthew R. Smith, Francis J. McGovern, Mary Anne Fallon, David Schoenfeld, Philip W. Kantoff, Joel S. Finkelstein

Journal:

Year:

2001

Language:

english

File:

PDF, 128 KB

english, 2001

16

Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy

Andrew Z. Wang, Vaishali Bagalkot, Christophoros C. Vasilliou, Frank Gu, Frank Alexis, Liangfang Zhang, Mariam Shaikh, Kai Yuet, Michael J. Cima, Robert Langer, Philip W. Kantoff, Neil H. Bander, Sang

Journal:

Year:

2008

Language:

english

File:

PDF, 500 KB

english, 2008

17

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma : Report of four cases

William K. Oh, Daniel J. George, Philip W. Kantoff

Journal:

Year:

2002

Language:

english

File:

PDF, 247 KB

english, 2002

18

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

Anthony V. D'Amico, Tara Saegaert, Ming-Hui Chen, Andrew A. Renshaw, Daniel George, William Oh, Philip W. Kantoff

Journal:

Year:

2002

Language:

english

File:

PDF, 80 KB

english, 2002

19

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma : A Phase II study of letrozole

Matthew R. Smith, Donald Kaufman, Daniel George, William K. Oh, Maryanne Kazanis, Judith Manola, Philip W. Kantoff

Journal:

Year:

2002

Language:

english

File:

PDF, 61 KB

english, 2002

20

Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma

William K. Oh, Patrice Tully, Philip W. Kantoff, Meredith M. Regan

Journal:

Year:

2003

Language:

english

File:

PDF, 116 KB

english, 2003

21

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

Matthew R. Smith, Judith Manola, Donald S. Kaufman, Daniel George, William K. Oh, Elisabetta Mueller, Susan Slovin, Bruce Spiegelman, Eric Small, Philip W. Kantoff

Journal:

Year:

2004

Language:

english

File:

PDF, 88 KB

english, 2004

22

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

M. Dror Michaelson, Donald S. Kaufman, Philip Kantoff, William K. Oh, Matthew R. Smith

Journal:

Year:

2006

Language:

english

File:

PDF, 118 KB

english, 2006

23

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

Mari Nakabayashi, Wanling Xie, Meredith M. Regan, David M. Jackman, Philip W. Kantoff, William K. Oh

Journal:

Year:

2006

Language:

english

File:

PDF, 92 KB

english, 2006

24

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer : Association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect

Robert W. Ross, Wanling Xie, Meredith M. Regan, Mark Pomerantz, Mari Nakabayashi, Timothy J. Daskivich, Oliver Sartor, Mary-Ellen Taplin, Philip W. Kantoff, William K. Oh

Journal:

Year:

2008

Language:

english

File:

PDF, 193 KB

english, 2008

25

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

Anthony V. D'Amico, Ming-Hui Chen, Andrew A. Renshaw, Marian Loffredo, Philip W. Kantoff

Journal:

Year:

2008

Language:

english

File:

PDF, 194 KB

english, 2008

26

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

Toni K. Choueiri, Wanling Xie, Anthony V. D'Amico, Robert W. Ross, Jim C. Hu, Mark Pomerantz, Meredith M. Regan, Mary-Ellen Taplin, Philip W. Kantoff, Oliver Sartor, William K. Oh

Journal:

Year:

2009

Language:

english

File:

PDF, 229 KB

english, 2009

27

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

Paul L. Nguyen, Ming-Hui Chen, Clair J. Beard, W. Warren Suh, Toni K. Choueiri, Jason A. Efstathiou, Karen E. Hoffman, Marian Loffredo, Philip W. Kantoff, Anthony V. D'Amico

Journal:

Year:

2010

Language:

english

File:

PDF, 156 KB

english, 2010

28

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

William K. Oh, Roberto Vargas, Susanna Jacobus, Kim Leitzel, Meredith M. Regan, Peter Hamer, Karen Pierce, Sheryl Brown-Shimer, Walter Carney, Suhail M. Ali, Philip W. Kantoff, Allan Lipton

Journal:

Year:

2011

Language:

english

File:

PDF, 220 KB

english, 2011

29

Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study

Lorelei A. Mucci, Jennifer R. Stark, William D. Figg, Fredrick Schumacher, Haojie Li, Miyako Abe, Kristen Hennessy, Meir J. Stampfer, John Michael Gaziano, Jing Ma, Philip W. Kantoff

Journal:

International Journal of Cancer

Year:

2009

Language:

english

File:

PDF, 74 KB

english, 2009

30

Effect of finasteride on risk of prostate cancer: How little we really know

Mark A. Rubin, Philip W. Kantoff

Journal:

Journal of Cellular Biochemistry

Year:

2004

Language:

english

File:

PDF, 233 KB

english, 2004

31

Bladder cancer

Philip W. Kantoff

Journal:

Current Problems in Cancer

Year:

1990

Language:

english

File:

PDF, 3.91 MB

english, 1990

32

Rate of relapse following treatment for localized prostate cancer: A critical analysis of retrospective reports

C.Norman Coleman, Clair J. Beard, Philip W. Kantoff, Rebecca Gelman

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1994

Language:

english

File:

PDF, 1.35 MB

english, 1994

33

Interval to Testosterone Recovery After Hormonal Therapy for Prostate Cancer and Risk of Death

Anthony V. D'Amico, Ming-Hui Chen, Andrew A. Renshaw, Marian Loffredo, Philip W. Kantoff

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2009

Language:

english

File:

PDF, 216 KB

english, 2009

34

Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations

Paul L. Nguyen, Ming-Hui Chen, Andrew A. Renshaw, Marian Loffredo, Philip W. Kantoff, Anthony V. D'Amico

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2010

Language:

english

File:

PDF, 137 KB

english, 2010

35

Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group

Paul L. Nguyen, Ming-Hui Chen, Clair J. Beard, W. Warren Suh, Andrew A. Renshaw, Marian Loffredo, Elizabeth McMahon, Philip W. Kantoff, Anthony V. D'Amico

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2010

Language:

english

File:

PDF, 354 KB

english, 2010

36

Male Patients with Diagnoses of Both Breast Cancer and Prostate Cancer

Stacey B. Leibowitz, Judy E. Garber, Edward A. Fox, Massimo Loda, Donald S. Kaufman, Philip W. Kantoff, William K. Oh

Journal:

The Breast Journal

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

37

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

Andrea Sboner, Francesca Demichelis, Stefano Calza, Yudi Pawitan, Sunita R Setlur, Yujin Hoshida, Sven Perner, Hans-Olov Adami, Katja Fall, Lorelei A Mucci, Philip W Kantoff, Meir Stampfer, Swen-Olof

Journal:

BMC Medical Genomics

Year:

2010

Language:

english

File:

PDF, 1.34 MB

english, 2010

38

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes

Bo-Ying Bao, Bin-Fay Chuang, Qianben Wang, Oliver Sartor, Steven P. Balk, Myles Brown, Philip W. Kantoff, Gwo-Shu Mary Lee

Journal:

Year:

2008

Language:

english

File:

PDF, 298 KB

english, 2008

39

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer

Mari Nakabayashi, Meredith M. Regan, Deborah Lifsey, Philip W. Kantoff, Mary-Ellen Taplin, Oliver Sartor, William K. Oh

Journal:

BJU International

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

40

GENETIC DETERMINANTS OF PROSTATE CANCER RISK

Mark M. Pomerantz, Matthew L. Freedman, Philip W. Kantoff

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 102 KB

english, 2007

41

PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A DECISION-ANALYTICAL PERSPECTIVE

Julia H. Hayes, Michael J. Barry, Philip W. Kantoff, James E. Stahl

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 66 KB

english, 2007

42

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

Mari Nakabayashi, Oliver Sartor, Susanna Jacobus, Meredith M. Regan, David McKearn, Robert W. Ross, Philip W. Kantoff, Mary-Ellen Taplin, William K. Oh

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 86 KB

english, 2008

43

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones

Mary-Ellen Taplin, Judith Manola, William K. Oh, Philip W. Kantoff, Glenn J. Bubley, Matthew Smith, Diana Barb, Christos Mantzoros, Edward P. Gelmann, Steven P. Balk

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 132 KB

english, 2008

44

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer

Mari Nakabayashi, William K. Oh, Susanna Jacobus, Meredith M. Regan, Mary-Ellen Taplin, Philip W. Kantoff, Jonathan E. Rosenberg

Journal:

BJU International

Year:

2010

Language:

english

File:

PDF, 260 KB

english, 2010

45

Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer

Miyako Abe, Wanling Xie, Meredith M. Regan, Irena B. King, Meir J. Stampfer, Philip W. Kantoff, William K. Oh, June M. Chan

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 302 KB

english, 2011

46

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy

Dipika Misra, Wanling Xie, Meredith M. Regan, Robert W. Ross, Gwo-shu Lee, Doris Germain, Philip W. Kantoff, William K. Oh

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 326 KB

english, 2011

47

Sipuleucel-T

Higano, Celestia S., Small, Eric J., Schellhammer, Paul, Yasothan, Uma, Gubernick, Steven, Kirkpatrick, Peter, Kantoff, Philip W.

Journal:

Nature Reviews Drug Discovery

Year:

2010

Language:

english

File:

PDF, 200 KB

english, 2010

48

Antiandrogens in Prostate Cancer

Phillip Reid, Philip Kantoff, William Oh

Journal:

Investigational New Drugs

Year:

1999

Language:

english

File:

PDF, 111 KB

english, 1999

49

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer

Matthew R. Smith, Philip W. Kantoff

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 146 KB

english, 2002

50

Advances in the Treatment of Prostate Cancer

Pomerantz, Mark, Kantoff, Philip

Journal:

Annual Review of Medicine

Year:

2007

Language:

english

File:

PDF, 183 KB

english, 2007